Suppr超能文献

T1期肺腺癌患者术前预测肿瘤亚型及预后的因素识别

Identification of Factors for the Preoperative Prediction of Tumour Subtype and Prognosis in Patients with T1 Lung Adenocarcinoma.

作者信息

Zhu Wang-Yu, Zhang Yong-Kui, Chai Zhen-da, Hu Xiao-Fei, Tan Lin-Lin, Wang Zhao-Yu, Chen Zhi-Jun, Le Han-Bo

机构信息

Laboratory of Cytobiology and Molecular Biology, Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang 316021, China; Lung Cancer Research Centre, Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang 316021, China.

Lung Cancer Research Centre, Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang 316021, China; Department of Cardio-Thoracic Surgery, Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang 316021, China.

出版信息

Dis Markers. 2016;2016:9354680. doi: 10.1155/2016/9354680. Epub 2016 Dec 26.

Abstract

Identification of factors that can predict the subtypes of lung adenocarcinoma preoperatively is important for selecting the appropriate surgical procedure and for predicting postoperative survival. We retrospectively evaluated 87 patients with lung adenocarcinomas ≤30 mm. Preoperative radiological findings, serum CEA level, serum microRNA-183 (miR-183) level, and tumour size differed significantly between patients with adenocarcinoma in situ (AIS) or minimally invasive adenocarcinoma (MIA) and those with invasive adenocarcinoma (IAC). Receiver operating characteristic curves and univariate analysis revealed that patients who were older than 57 years or had a pure solid nodule or a tumour with mixed ground-glass opacity (mGGO), a tumour >11 mm, a serum CEA level >2.12 ng/mL, or a serum miR-183 level >1.233 (2) were more likely to be diagnosed with IAC than with AIS or MIA. The combination of all five factors had an area under the curve of 0.946, with a sensitivity of 89.13% and a specificity of 95.12%. Moreover, patients with a cut-off value >0.499 for the five-factor combination had poor overall survival. The five-factor combination enables clinicians to distinguish AIS or MIA from IAC, thereby aiding in selecting the appropriate treatment, and to predict the prognosis of lung adenocarcinoma patients.

摘要

术前识别可预测肺腺癌亚型的因素对于选择合适的手术方式及预测术后生存率至关重要。我们回顾性评估了87例肿瘤直径≤30 mm的肺腺癌患者。原位腺癌(AIS)或微浸润腺癌(MIA)患者与浸润性腺癌(IAC)患者的术前影像学表现、血清癌胚抗原(CEA)水平、血清微小RNA-183(miR-183)水平及肿瘤大小存在显著差异。受试者工作特征曲线及单因素分析显示,年龄大于57岁、具有纯实性结节或混合性磨玻璃密度影(mGGO)的肿瘤、肿瘤直径>11 mm、血清CEA水平>2.12 ng/mL或血清miR-183水平>1.233(2)的患者被诊断为IAC而非AIS或MIA的可能性更大。这五个因素联合应用时曲线下面积为0.946,灵敏度为89.13%,特异度为95.12%。此外,五因素联合值>0.499的患者总生存期较差。五因素联合可使临床医生区分AIS或MIA与IAC,从而有助于选择合适的治疗方法,并预测肺腺癌患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6694/5220495/9aa5b86557d4/DM2016-9354680.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验